May 16, 2024 • 7:00 AM EDT New In Vitro Data Showing Matinas BioPharma’s LNC Platform Delivering Small Oligonucleotides Presented at TIDES USA 2024
May 9, 2024 • 4:05 PM EDT Matinas BioPharma Reports First Quarter 2024 Financial Results and Provides a Business Update
May 7, 2024 • 8:00 AM EDT Matinas BioPharma’s LNC Platform for the Delivery of Small Oligonucleotides Featured in Two Presentations at the ASGCT Annual Meeting